GYRE
XNASGYRE THERAPEUTICS INC
Avg. sentiment
0.50bullish
1 news · 90d
7d trend
——
0 news · vs previous 7d (—)
Breakdown
↑ 1• 0↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
Price
Sentiment (7d avg)
1 news · hover dots for detailsTrack $GYRE sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- GlobalNewswire5/4/2026, 12:47:00 PMGyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
Gyre Therapeutics has completed its acquisition of Cullgen, forming a fully integrated biopharmaceutical company with operations in both the U.S. and China. The deal is confirmed as closed, combining Gyre's existing platform with Cullgen's capabilities. No financial terms were disclosed in the announcement.
Sentiment 0.50Relevance 100%